/
The process required by the FDA before drugs may be marketed in the U.S. generally involves the following: completion of non-clinical laboratory tests, animal studies and formulation studies conducted according to good laboratory practice or other applicable regulations; submission of an IND, which must become effective before human clinical trials may be initiated; 15 adequate and well-control…
ROIC dropped from -19.37% to -40.87%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$472M
▼ -227.1% YoY
Op. Margin
—
ROIC
-59.83%
▼ -21.5pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$340M
▼ -217.4% YoY
Net Debt
-$603M
Net Cash Position
Cash & Equiv.
$603M
Continue Research